Vanguard Group’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
|
|||||
|
2025
Q1 | $1.98M | Buy |
|
|||||
|
2024
Q4 | $1.2M | Buy |
|
|||||
|
2024
Q3 | $1.23M | Buy |
|
|||||
|
2024
Q2 | $930K | Buy |
|
|||||
|
2024
Q1 | $1.64M | Buy |
|
|||||
|
2023
Q4 | $1.46M | Buy |
|
|||||
|
2023
Q3 | $1.19M | Buy |
|
|||||
|
2023
Q2 | $672K | Buy |
|
|||||
|
2023
Q1 | $374K | Hold |
|
|||||
|
2022
Q4 | $523K | Buy |
|
|||||
|
2022
Q3 | $592K | Sell |
|
|||||
|
2022
Q2 | $878K | Buy |
|
|||||
|
2022
Q1 | $1.35M | Sell |
|
|||||
|
2021
Q4 | $2.62M | Buy |
|
|||||
|
2021
Q3 | $8.8M | Buy |
|
|||||
|
2021
Q2 | $3.29M | Sell |
|
|||||
|
2021
Q1 | $13.9M | Buy |
|